GCANRx Announces Completion of Preclinical Study for : vimarsana.com

BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company...

Related Keywords

Jerusalem , Israel General , Israel , Hebrew University , Yerushalayim , Boston , Massachusetts , United States , Adi Aran , Aitan Zacharin , Intel , Google , Boston Scientific , Twitter , Exchange Commission , Hebrew University Of Jerusalem , Johnson , Greater Cannabis Company , Greater Cannabis Company Inc , Novartis , Securities Exchange , Yissum Research Development Company , Cannabis Company , Shaare Zedek Scientific , Professor Tal Burstyn Cohen , Reactive Oxygen Species , Investor Relations , Safe Harbor Statement , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Looking Statements , Other Otc Gcan , He Greater Cannabis Company , Nc , Reater Cannabis Company , Canrx , Reclinical Study , Europsychiatric , Annabinoid Therapy , Tc Gcan , Iopharmaceutical ,